When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions. So, what promise do they hold as therapeutics? Albert Garcia-Romeu, a researcher at John’s Hopkins University, joins Dr. Sanjay Gupta to talk about how psychedelics can alleviate mental suffering and what the path forward might look like.
Patrick McGee: “Apple in China: The Capture of the World’s Greatest Company” | The Daily Show
Award-winning journalist Patrick McGee joins Jon Stewart to discuss how Apple built China in his new book “Apple in China: The Capture of the World’s…
Thought Leader: Patrick McGee
Peter Zeihan: The Fire Hose of Chaos: The “Deal” With the Chinese
Trade tensions are taking their toll on an already fragile Chinese system. The US is dealing with self-sufficiency problems, but for China, it is an…
Thought Leader: Peter Zeihan
Apple’s Chinafication with Patrick McGee | American Compass Podcast
The company’s corporate story is really about China, and how it came to dominate global industry. The Trump administration’s new trade policy toward China has…
Thought Leader: Patrick McGee
